News and
Updates

How Your Gut Microbiome Prevents the Loss of Muscle Mass

Maintaining muscle strength and mass as we age is crucial for overall health and quality of life. Recent research highlights a promising dietary approach to combatting age-related muscle decline. Read more

FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome

Sarasota, Florida, May 08, 2024 (GLOBE NEWSWIRE) — BIOM Pharmaceutical Corporation is thrilled to announce that Bi104, its innovative drug product, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of Angelman syndrome (AS). Read more

Biom Enhances Safety Measures With Completion Of Osha 10-hour General Industry Certification Program

Biom Pharmaceutical Corporation, a leading provider in microbiome technology, is pleased to announce the successful completion of OSHA’s 10-Hour General Industry Certification program by employees across multiple departments, including Manufacturing, Quality Control, and Supply Chain. Read more

 VagiBiom^® Feminine Support Suppositories Are Now Available in Publix Stores

BIOM Pharmaceutical Corporation (BIOM), a biotech company focused on natural microbiome-based consumer and medical products, today announced that it has launched two VagiBIOM^® feminine care products in Publix, a leading supermarket and grocery chain in the Southeast United States with 1367 stores. Read more

Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women’s Health

VagiBiom® microbiome-based probiotic suppositories have shown to be safe and efficacious in significantly improving symptoms and the vaginal health index in reproductive age and perimenopausal women with Bacterial Vaginosis. The double-blind, placebo-controlled clinical study was recently published in the internationally known publication “Scientific Reports.”. Read More

VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial

Bacterial vaginosis (BV) can cause vaginal dysbiosis that may influence general vaginal health and pregnancy complications. Read More

Gardner Joins BIOM Pharmaceutical as Board Chairman

BIOM Pharmaceutical Corporation, an emerging biotech company focused on human microbiome technologies, is pleased to announce the appointment of Thomas E. Gardner as Chairman of the BIOM Board of Directors. Read More

Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2

The SARS-CoV-2 pandemic has infected over 762 million people with over 6.9 million deaths, markedly affecting human life and existence. In the US alone, over 1.12 million deaths have been reported as of March 2023. Since its first report, several SARS-CoV-2 lineages evolved in the last 24 to 30 months. Read More

“Consumers are increasingly aware of the importance of cognitive and brain health in longevity,” says Bobban Subhadra, Ph.D., CEO & Founder, Biom Probiotics. “Traditionally, it was all about brain-boosting supplements. However, with the new research on gut microbiome—your gut good flora with its genetic elements and metabolites—it is obvious that gut flora plays a key role in optimizing cognitive brain health, which we call as microbiota-gut-brain-axis. Specifically, metabolites produced by gut flora, such as short-chain fatty acids play a key role in brain health and also prevent vascular dementia.”